Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Iradimed (IRMD) Deferred Taxes (2016 - 2025)

Iradimed (IRMD) has disclosed Deferred Taxes for 13 consecutive years, with -$2.3 million as the latest value for Q4 2025.

  • Quarterly Deferred Taxes fell 2293.64% to -$2.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$2.7 million through Dec 2025, down 490.69% year-over-year, with the annual reading at -$2.7 million for FY2025, 490.69% down from the prior year.
  • Deferred Taxes for Q4 2025 was -$2.3 million at Iradimed, down from -$134872.0 in the prior quarter.
  • The five-year high for Deferred Taxes was $1.6 million in Q2 2024, with the low at -$2.3 million in Q4 2025.
  • Average Deferred Taxes over 5 years is -$71889.8, with a median of -$94084.0 recorded in 2021.
  • The sharpest move saw Deferred Taxes surged 1131.55% in 2023, then tumbled 2293.64% in 2025.
  • Over 5 years, Deferred Taxes stood at -$109512.0 in 2021, then plummeted by 159.54% to -$284230.0 in 2022, then surged by 124.29% to $69042.0 in 2023, then surged by 53.78% to $106171.0 in 2024, then crashed by 2293.64% to -$2.3 million in 2025.
  • According to Business Quant data, Deferred Taxes over the past three periods came in at -$2.3 million, -$134872.0, and -$133533.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.